School of Medicine
Showing 21-30 of 52 Results
-
Kathleen Watson
Instructor, Psychiatry and Behavioral Sciences
BioKathleen Watson, Ph.D., currently serves as an instructor at Stanford University School of Medicine, specializing in Epidemiology and Clinical Research. She co-founded Microclinic International in 2007, where she served as Chief Operating Officer until 2012, focusing on socially-based health interventions for underserved communities.
Dr. Watson's research encompasses various aspects of mental health and metabolism. She investigates the connection between insulin resistance and depression, using computational psychiatry to uncover insights into the interplay of metabolic factors in mental well-being. Additionally, her exploration of cognitive aging examines how metabolic alterations might impact cognitive decline and related disorders. Furthermore, her research in proteomics aims to identify potential biomarkers for severe major depressive disorder. Dr. Watson has recently become a part of the Stanford Autism Center for Excellence Data Core, where she works under the guidance of Dr. Booil Jo. -
M. Brandon Westover, MD, PhD
Professor of Neurology and Neurological Sciences (Adulty Neurology) and, by courtesy, of Biomedical Data Science and of Psychiatry and Behavioral Sciences
BioDr. M. Brandon Westover is a board-certified, fellowship-trained epilepsy specialist, clinical neurophysiologist, and neurologist with Stanford Health Care. He is also a professor in the Department of Neurology and Neurological Sciences at Stanford University School of Medicine and director of the Stanford Epilepsy Center.
Dr. Westover specializes in caring for adults with epilepsy and other neurological conditions. He focuses on developing automated tools that improve the quality and reach of his patients' care. He also treats patients with life-threatening unrelenting seizures (status epilepticus), reduced blood flow to the brain (cerebral ischemia), and reduced oxygen to the brain (anoxic brain injury). In addition, he helps patients experiencing delirium, seizures, and sleep disorders.
Dr. Westover's research develops artificial intelligence technology to protect and improve brain health. His interests include predicting seizures and detecting and forecasting disorders of memory, cognition, and consciousness—such as delirium and coma—in older adults. His work has also used deep learning to estimate the risk of developing epilepsy after a brain injury from brain-wave recordings (electroencephalograms, or EEGs).
Dr. Westover has published his research in leading peer-reviewed journals, including Neurology, JAMA Neurology, Annals of Neurology, Epilepsia, the Journal of the American Medical Informatics Association, and Lancet Digital Health. He has presented his work at international, national, and regional meetings, including the annual meetings of the American Epilepsy Society, the American Clinical Neurophysiology Society, the American Academy of Neurology, and SLEEP.
